Concepedia

ADORA2A rs5760423 and CYP1A2 rs762551 Polymorphisms as Risk Factors for Parkinson’s Disease

Vasileios Siokas, Athina‐Maria Aloizou, Zisis Tsouris, Ioannis Liampas, Panagiotis Liakos, Daniela Călina, Anca Oana Docea, Aristidis Tsatsakis, Dimitrios P. Bogdanos, Georgios M. Hadjigeorgiou,

Journal of Clinical Medicine · 2021 · 28 citations · 31 references

DOIFull text

Open access

Abstract

Based on our analyses, it appears rather unlikely that <i>ADORA2A rs5760423</i> or <i>CYP1A2 rs762551</i> is among the major risk factors for PD, at least in Greek patients with PD.

References

31

Meta-analysis in clinical trials

Rebecca DerSimonian, Nan M. Laird · Controlled Clinical Trials · 1986 · 38.5K citations

, , +6

Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease

Nathan Mantel, William Haenszel · JNCI Journal of the National Cancer Institute · 1959 · 14.8K citations

, , +18

Staging of brain pathology related to sporadic Parkinson’s disease

Heiko Braak, Kelly Del Tredici, Udo Rüb et al. · Neurobiology of Aging · 2002 · 10.5K citations

, , +6

Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease

Mihael H. Polymeropoulos, Christian Lavedan, Elisabeth Leroy et al. · Science · 1997 · 8.2K citations

The Combination of Estimates from Different Experiments

William G. Cochran · Biometrics · 1954 · 5.2K citations

, , +13